VRQOL in Cataract Patients During the COVID-19 Pandemic

• Conditions: Senile Cataract

• Registration Number: NCT04468308
• Lead Sponsor: Medical University Innsbruck

Brief Summary

The aim of this questionnaire survey is to evaluate the improvement in vision-related quality of life before and after cataract surgery using the National Eye Institute Visual Function Questionnaire 25 and the delay of improvement in the COVID-19 pandemic.

Detailed Description

Not available

Study Timeline

• Status Verified: 2020-06
• Study First Submitted: 2020-06-22
• Study First Submitted QC: 2020-07-10
• Study First Posted: 2020-07-13
• Study Start: 2020-09-08
• Last Update Submitted: 2020-09-22
• Last Update Posted: 2020-09-23
• Primary Completion: 2021-03
• Study Completion: 2021-03

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 116

Inclusion Criteria

• Age ≥ 50 years
• Senile cataract
• Indication for unilateral or bilateral cataract surgery
• Postponed cataract surgery due to the COVID-19 pandemic
• Signed and dated declaration of consent

Exclusion Criteria

• Complex form of cataract (traumatic cataract, secondary cataract after intraocular inflammation)
• Amblyopia on the eye that is to be operated on
• Severe, visually impairing eye disease on the eye that is to operated on
• Known dementia or memory problems

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Improvement Vision-related quality of life	3 months	Extent of improvement of vision-related qualitiy of life due to cataract surgery measured with the National Eye Institut Visual Function Questionnaire 25.

Secondary Outcome Measures

Name	Time	Method
Delay of Vision-related quality of life	3 months	Delay of improvement of vision-related qualitiy of life in the COVID-19 pandemic measured in days between the originally scheduled operation and the actual operation date
Visual acuity	1 month	Visual acuity difference between visual acuity at the time of indication for cataract surgery, on the day of surgery and one month postoperatively.

Trial Locations

Locations (1)

Medical University Innsbruck; 🇦🇹 Innsbruck, Tyrol, Austria